Biphasic Medium Using Nicotinamide for Detection of Pyrazinamide Resistance in

Waraporn Thuansuwan, Charoen Chuchottaworn, Chie Nakajima, Yasuhiko Suzuki, Nuntaree Chaichanawongsaroj

Abstract read

In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Enhancing diagnostic efficiency of pyrazinamide resistance inCurrent research in microbial sciences · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Waraporn ThuansuwanProgram of Molecular Sciences in Medical Microbiology and Immunology, Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Charoen ChuchottawornCentral Chest Institute of Thailand, Bangkasor, Muang, Nonthaburi 11000, Thailand.

Chie NakajimaInternational Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.

Yasuhiko SuzukiInternational Institute for Zoonosis Control, Hokkaido University, Sapporo 001-0020, Japan.ORCID 0000-0002-1313-1494

Nuntaree ChaichanawongsarojResearch Unit of Innovative Diagnosis of Antimicrobial Resistance, Department of Transfusion Medicine and Clinical Microbiology, Faculty of Allied Health Sciences, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand.

Funding

Japan Agency for Medical Research and Development (AMED) JP24jm0110021, JP24wm0125008 and JP243fa627005 to YSRatchadaphiseksomphot Endowment Fund, Chulalongkorn University CU-GR_60_43_37_02

6 · The paper itself

Abstract

Reliable drug susceptibility testing of pyrazinamide (PZA) is technically difficult, since PZA activity is pH sensitive. The aim of this study was to evaluate a biphasic medium assay (BMA) for the reliable detection of PZA resistance in

Indexed as

biphasic mediaMycobacterium tuberculosisnicotinamidepncApyrazinamide

Identifiers

PMID38927229

DOI10.3390/antibiotics13060563

PMCPMC11200442

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.